This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ecole Polytechnique Federale De Lausanne. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Work of Eleonora Simeoni in Immunotherapy
Introduction
Eleonora Simeoni is a distinguished inventor based in Bottens, Switzerland. With her notable contribution to the field of medical technology, she has developed a unique innovation in the realm of immunotherapy. Her inventive spirit and dedication to advancing science highlight her importance in the advancement of medical treatments.
Latest Patents
Eleonora holds a patent for her work on "Nanoparticles for Immunotherapy." This groundbreaking invention focuses on nanoparticles that activate the complement system in the absence of biological molecules. These specially designed nanoparticles specifically target antigen-presenting cells within lymph nodes, providing a novel method for delivering immunotherapeutics without relying on biological targeting molecules. The patent details various surface chemistries and chemical formulations for these nanoparticles, showcasing their potential as viable vehicles in immunotherapy treatments.
Career Highlights
Currently, Eleonora is affiliated with the École Polytechnique Fédérale de Lausanne, where she continues her research and development efforts. Her work has the potential to revolutionize immunotherapy, providing new avenues for treating various diseases that require an enhanced immune response.
Collaborations
In her innovative journey, Eleonora has collaborated with notable colleagues, including Jeffrey Alan Hubbell and Conlin P O'Neil. These partnerships highlight the collaborative nature of scientific research, as they contribute different expertise to advance the development of her groundbreaking nanoparticle technology.
Conclusion
Eleonora Simeoni's contributions to the field of immunotherapy, particularly through her patented work on nanoparticles, mark significant progress in medical technology. Her continued research endeavors at École Polytechnique Fédérale de Lausanne, along with her collaborative efforts with esteemed colleagues, fortify her role as a leading inventor in modern science. As innovations in immunotherapy evolve, Eleonora's work stands as a testament to the impactful role that inventors play in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile